Ultragenyx 製藥公司 - 資產負債表 (Quarterly)

Ultragenyx 製藥公司
DE ˙ DB ˙ US90400D1081
€19.80 ↓ -0.17 (-0.88%)
2026-05-29
分享價格
資產負債表 (Quarterly)

Ultragenyx 製藥公司資產負債表反映公司在特定時間點的帳戶餘額。財務狀況表數據包括資產、流動資產、固定資產、不動產、廠房和設備(PPE)、存貨、無形資產、負債、流動負債、長期負債、融資租賃負債、普通股、保留盈利、庫存股和股東權益。

除以每股為單位的數字外,所有數字為1,000,000.00倍數。

2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
2025
09-30
2025
12-31
2026
03-31
現金 291 198 308 154 160 392 133 86 102 73 214 112 481 137 174 127 176 203 421 175
改變 (%) -32.09 55.71 -49.94 3.82 144.98 -66.06 -35.49 18.99 -28.89 194.29 -47.44 328.23 -71.60 27.45 -26.98 38.76 14.86 107.89 -58.43
流動資產 949 847 857 708 679 1,013 884 766 702 599 732 596 965 800 817 699 720 643 951 657
改變 (%) -10.81 1.15 -17.40 -4.10 49.24 -12.72 -13.30 -8.38 -14.66 22.20 -18.60 61.86 -17.11 2.18 -14.42 2.95 -10.64 47.85 -30.91
資產 1,512 1,485 1,522 1,384 1,321 1,618 1,545 1,383 1,311 1,238 1,491 1,307 1,618 1,538 1,503 1,312 1,306 1,190 1,532 1,296
改變 (%) -1.83 2.53 -9.09 -4.58 22.55 -4.51 -10.49 -5.21 -5.58 20.42 -12.34 23.82 -4.95 -2.30 -12.71 -0.43 -8.87 28.69 -15.40
負債 540 551 600 588 643 1,150 1,193 1,163 1,182 1,206 1,216 1,167 1,186 1,185 1,241 1,161 1,148 1,174 1,605 1,525
改變 (%) 2.01 8.84 -2.04 9.35 78.92 3.77 -2.52 1.66 2.04 0.76 -4.01 1.65 -0.13 4.77 -6.47 -1.09 2.29 36.68 -4.98
公平 972 934 923 796 678 469 352 220 129 32 275 140 432 354 262 151 158 16 -73 -229
改變 (%) -3.96 -1.19 -13.67 -14.86 -30.86 -24.81 -37.45 -41.48 -75.42 768.43 -49.07 208.29 -18.17 -25.95 -42.27 4.65 -89.79 -551.76 213.70
負債和股本 1,512 1,485 1,522 1,384 1,321 1,618 1,545 1,383 1,311 1,238 1,491 1,307 1,618 1,538 1,503 1,312 1,306 1,190 1,532 1,296
改變 (%) -1.83 2.53 -9.09 -4.58 22.55 -4.51 -10.49 -5.21 -5.58 20.42 -12.34 23.82 -4.95 -2.30 -12.71 -0.43 -8.87 28.69 -15.40

Source: Capital IQ

How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
US:RARE US$23.31
GB:0LIF US$21.92
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista